Biomoneta Secures US FDA Class II Clearance for Avata Rx MM Desk 3 December, 2025 Biomoneta Research Private Limited, a Bengaluru-based health technology company, has achieved a major milestone with Read More
Aurobindo Pharma Develops 14 Biosimilar Products MM Desk 4 September, 2024 Aurobindo Pharma, a prominent player in the generic pharmaceutical industry, is significantly broadening its specialty Read More
Aurobindo Pharma’s Rajasthan Facility Wraps Up US FDA Audit with 9 Observations MM Desk 6 May, 2024 Aurobindo Pharma, a leading pharmaceutical company, has announced the conclusion of a United States Food Read More